Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DCAKD | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | RPS6KL1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | FAM170B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ZNHIT6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | MRPS15 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | PRUNE1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RGS14 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | ROPN1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ASF1B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ZRSR1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |